NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE85336 Query DataSets for GSE85336
Status Public on Sep 26, 2016
Title Exogenous remodeling of the lung macrophage microenvironment protects against infectious consequences of bone marrow ablative chemotherapy
Organism Mus musculus
Experiment type Expression profiling by array
Summary Infection is the single greatest threat to survival during cancer chemotherapy because of depletion of bone marrow derived immune cells. In the absence of phagocytes such as neutrophil, vaccine-induced humoral and cellular anti-pathogen immunity are compromised. Using a model of vaccine-induced protection against lethal P. aeruginosa pneumonia in the setting of chemotherapy-induced neutropenia, we found a population of resident lung macrophages in the immunized lung that mediated protection in the absence of neutrophils, bone marrow derived monocytes, or antibodies. These vaccine-induced macrophages (ViMs) expanded after immunization, locally proliferated, and were closely related to alveolar macrophages (AMs) by surface phenotype and gene expression profiles. By contrast to AMs, numbers of ViMs were stable through chemotherapy, show enhanced phagocytic activity, and prolonged survival of neutropenic mice from lethal P. aeruginosa pneumonia upon intratracheal adoptive transfer. Thus, induction of ViMs by tissue macrophage remodeling may become a framework for new strategies to activate immune-mediated reserves against infection in immunocompromised hosts.
 
Overall design We compared the global transcription profiles of three different populations of resident lung macrophages in mice following intranasal immunization with a live-attenuated Pseudomonas aeruginosa vaccine (strain PAO1ΔaroA) with or without cyclophosphamide (CY) treatment. Macrophages were isolated from collagenase-digested whole lung at 4 weeks after 3 weekly doses of immunization with or without CY (150mg/kg/dose i.p.) on days -6, -4, -2 of harvest. Overall, there were three treatment groups: Control (unvaccinated, no CY treatment), Vac only (vaccinated but not treated with CY), or Vac+CY (vaccinated and CY-treated). Five mice from each treatment group were pooled and treated as a single sample for microarray analysis to guarantee enough number of cells for each assay. Each treatment group consisted of biologically independent triplicates which were processed in 3 independent experiments.
 
Contributor(s) Kamei A, Gao G, Neale G, Loh LN, Vogel P, Thomas PG, Tuomanen EI, Murray PJ
Citation(s) 27671632
Submission date Aug 08, 2016
Last update date Feb 21, 2018
Contact name Geoffrey Neale
E-mail(s) geoffrey.neale@stjude.org
Organization name St Jude Childrens Research Hospital
Department Hartwell Center
Street address 262 Danny Thomas Place
City Memphis
State/province TN
ZIP/Postal code 38105
Country USA
 
Platforms (1)
GPL16570 [MoGene-2_0-st] Affymetrix Mouse Gene 2.0 ST Array [transcript (gene) version]
Samples (24)
GSM2265071 Macrophage Population A, Vac+CY, replicate 1
GSM2265072 Macrophage Population A, Vac+CY, replicate 2
GSM2265073 Macrophage Population A, Vac+CY, replicate 3
Relations
BioProject PRJNA338187

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE85336_RAW.tar 199.9 Mb (http)(custom) TAR (of CEL)
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap